| Shire plc (SHPGY) Submits License Application for REPLAGAL® - TransWorldNews (press release) |
|
|
TransWorldNews (press release)It affects both males and females and can present a number of signs or symptoms of variable degree, such as cardiovascular and/or renal dysfunction, ...Rare Fabry Disease May Soon Receive New Treatment eMaxHealthShire Submits Biologics License Application With FDA For Replagal To Treat ... read more |